Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies

by Ardini, Elena, Siena, Salvatore
Published in ESMO Open (2020)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

by Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore
Published in ESMO Open (2016)

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials

by Koukakis, Reija, Gatta, Francesca, Hechmati, Guy, Siena, Salvatore
Published in Qual Life Res (2016)

Exploring the links between cancer and placenta development

by Costanzo, Vincenzo, Bardelli, Alberto, Siena, Salvatore, Abrignani, Sergio
Published in Open Biol (2018)

Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?

by Amatu, Alessio, Bencardino, Katia, Sartore-Bianchi, Andrea, Siena, Salvatore
Published 2013

Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases

by Andreano, Anita, Valsecchi, Maria Grazia, Russo, Antonio Giampiero, Siena, Salvatore
Published in Arch Public Health (2021)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

by Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Balfour, Julia, Bardelli, Alberto
Published 2009

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory...

by Poulin-Costello, Melanie, Azoulay, Laurent, Van Cutsem, Eric, Peeters, Marc, Siena, Salvatore, Wolf, Michael
Published 2013

Acquired resistance to EGFR‐targeted therapies in colorectal cancer

by Van Emburgh, Beth O., Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Siena, Salvatore, Bardelli, Alberto
Published in Mol Oncol (2014)

Early‐onset colorectal cancer in young individuals

by Mauri, Gianluca, Sartore‐Bianchi, Andrea, Russo, Antonio‐Giampiero, Marsoni, Silvia, Bardelli, Alberto, Siena, Salvatore
Published in Mol Oncol (2018)

Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib

by Sartore-Bianchi, Andrea, Lonardi, Sara, Aglietta, Massimo, Martino, Cosimo, Ciardiello, Fortunato, Marsoni, Silvia, Siena, Salvatore
Published in JAMA Oncol (2020)

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

by Amodio, Vito, Mauri, Gianluca, Reilly, Nicole M., Sartore-Bianchi, Andrea, Siena, Salvatore, Bardelli, Alberto, Germano, Giovanni
Published in Cancers (Basel) (2021)

The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review

by Lombardo, Roberta, Tosi, Federica, Nocerino, Annunziata, Bencardino, Katia, Gambi, Valentina, Ricotta, Riccardo, Spina, Francesco, Siena, Salvatore, Sartore-Bianchi, Andrea
Published in Front Oncol (2020)

Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

by Gandhi, Anita K., Shi, Tao, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Tabernero, Josep, Siena, Salvatore, Schafer, Peter H., Chopra, Rajesh
Published 2013

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

by Goldberg, Richard M, Montagut, Clara, Wainberg, Zev A, Ronga, Philippe, Audhuy, François, Taieb, Julien, Stintzing, Sebastian, Siena, Salvatore, Santini, Daniele
Published in ESMO Open (2018)

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

by Roncato, Rossana, Angelini, Jacopo, Pani, Arianna, Cecchin, Erika, Sartore-Bianchi, Andrea, Siena, Salvatore, De Mattia, Elena, Scaglione, Francesco, Toffoli, Giuseppe
Published in Int J Mol Sci (2020)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

by Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Published in ESMO Open (2016)

Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving...

by Taieb, Julien, Rivera, Fernando, Siena, Salvatore, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Gallego, Javier, Geissler, Michael, Koukakis, Reija, Demonty, Gaston, Peeters, Marc
Published in J Cancer Res Clin Oncol (2017)

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first...

by Peeters, Marc, Price, Timothy, Taieb, Julien, Geissler, Michael, Rivera, Fernando, Canon, Jean-Luc, Pentheroudakis, George, Koukakis, Reija, Burdon, Peter, Siena, Salvatore
Published in Br J Cancer (2018)

Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorect...

by Taieb, Julien, Rivera, Fernando, Siena, Salvatore, Karthaus, Meinolf, Valladares-Ayerbes, Manuel, Gallego, Javier, Geissler, Michael, Koukakis, Reija, Demonty, Gaston, Peeters, Marc
Published in J Cancer Res Clin Oncol (2018)